<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:department>School of Life Sciences</gtr:department><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/A2CE443A-4218-4D0E-AA0A-BB0C73680D8D"><gtr:id>A2CE443A-4218-4D0E-AA0A-BB0C73680D8D</gtr:id><gtr:firstName>Martin</gtr:firstName><gtr:surname>Gering</gtr:surname><gtr:orcidId>0000-0003-3763-0885</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MR%2FJ000841%2F1"><gtr:id>01B0D207-7E70-4F2F-B122-E58D573F2AF4</gtr:id><gtr:title>The transcriptome of haemogenic endothelium in zebrafish embryos</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/J000841/1</gtr:grantReference><gtr:abstractText>Every day, billions of blood cells die in our body and need to be replaced. Haematopoietic (blood) stem cells (HSCs) located in the bone marrow maintain the blood system throughout life. They give rise to all of the blood cells in our body, and retain the ability to divide to generate more HSCs in a process called self-renewal. These characteristics also enable HSCs to reinitiate blood formation in patients who through disease, injury or therapeutic treatment have lost their own HSCs and are unable to produce blood cells themselves. HSC transplants are, however, not without risks. Transplant rejection and graft-versus-host disease are frequent complications that can lead to the death of the patient. Pluripotent stem cells (cells that have the potential to become any cell type in our body) are a potential source of patient-matched or patient-specific HSCs that would allow us to avoid these complications. While we are able to generate mature blood cells from pluripotent cells, we currently lack sufficient knowledge to guide the cells to become HSCs. All vertebrates first form HSCs during embryogenesis and they appear to do this in a very similar way. In all vertebrate embryos, HSCs arise from haemogenic (blood-forming) endothelium located in the wall of the dorsal aorta, the main trunk artery. Using a transgenic zebrafish line in which haemogenic endothelial cells are marked by the expression of a green fluorescent protein we want to isolate these cells and find out which genes are expressed (switched on) within them. This information will help us to unravel the genetic programme that steers cells in the embryo to become HSCs. This project on zebrafish embryos promises to make a valuable contribution to our knowledge about HSC formation in the embryo which will help us in the future to generate HSCs from pluripotent cells grown in a culture dish.</gtr:abstractText><gtr:technicalSummary>In the vertebrate embryo, haematopoietic stem cells arise in the ventral wall of the dorsal aorta via an endothelial intermediate, the haemogenic endothelium. Little is known about the molecular programme that drives this process. Here, we propose to analyse in detail the transcriptome of the haemogenic endothelium and to compare it to that of non-haemogenic endothelial cells. For this purpose, we make use of a novel unique transgenic zebrafish line that allows us to isolate haemogenic endothelial cells from the zebrafish embryo by fluorescence-activated cell sorting. Total RNA will be prepared, mRNA reverse transcribed and amplified. Amplified cDNAs are used to generate a library for SOLiD sequencing. Genes up- or down-regulated in haemogenic endothelium in comparison to non-haemogenic and arterial endothelial cells will be verified by quantitative RT-PCR and RNA in situ hybridisation. Genes verified to be differentially expressed will be examined further in loss- and gain-of-function experiments to study their role in the process of haematopoietic stem cell formation.</gtr:technicalSummary><gtr:potentialImpactText>Haematopoietic stem cell (HSC) transplantations are the most common type of stem cell therapy performed in the clinic. However, allogeneic transplants bear the risk of transplant rejection or graft-versus-host disease, complications associated with significant morbidity and mortality. Pluripotent stem cells hold the promise to be an alternative source of transplantable HSCs that could overcome these problems. Unfortunately, efforts to generate HSCs from human embryonic stem cells have not been successful, mainly due to our limited understanding of the molecular program HSC precursors undergo during embryogenesis. In this project, we want to elucidate the transcriptome of the haemogenic endothelium, an endothelial intermediate that forms during HSC development. Thereby, we hope to provide insight into at least part of the molecular program that drives HSC formation in the vertebrate embryo. From this knowledge, new culture regimes may arise that will allow us to generate HSCs from pluripotent stem cells.</gtr:potentialImpactText><gtr:fund><gtr:end>2015-09-09</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2012-09-10</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>393818</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>2350</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Marie Curie Actions - Initial Training Network Consortium for Vascular Biology (VESSEL) - Associated Partner</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>European Union</gtr:fundingOrg><gtr:id>F7675AC3-3CE9-46C4-90EC-DE2CF68190A3</gtr:id><gtr:outcomeId>58c2e8a1ef2163.60242866</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>42129</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC PhD studentship</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>RS3614 (University of Nottingham Reference Number)</gtr:fundingRef><gtr:id>47FB7DA5-CC34-40A3-9E8D-048A33BB5694</gtr:id><gtr:outcomeId>56dc514a8fed04.03597971</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>90920</gtr:amountPounds><gtr:country>Saudi Arabia, Kingdom of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD studentship</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>Government of Saudi Arabia</gtr:fundingOrg><gtr:fundingRef>4243806</gtr:fundingRef><gtr:id>8E4D16E6-8CB3-44C4-965C-FF0F47FE4230</gtr:id><gtr:outcomeId>58c6bb145a8fe0.05368817</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>68350</gtr:amountPounds><gtr:country>Kuwait, State of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD Studentship</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>Kuwait University</gtr:fundingOrg><gtr:fundingRef>4258587</gtr:fundingRef><gtr:id>6E855845-5709-4888-9368-E38E6B49C855</gtr:id><gtr:outcomeId>58c69a2a782ca1.76040085</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>42000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC Studentship as part of BBSRC DTP (Biotechnology and Biological Sciences doctoral training programme)</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>RS86AD</gtr:fundingRef><gtr:id>D1478E2D-D1BB-4052-8DDC-0CA37C6CE428</gtr:id><gtr:outcomeId>58c2ecd51cb263.03929326</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>zebrafish lines gfi1ab qmc552 and gfi1ab qmc553 that carry mutations in gfi1ab</gtr:description><gtr:id>4C6660DB-3ADC-404C-9ED9-EF8A73784655</gtr:id><gtr:impact>these lines will help us to unravel the role of Gfi1 proteins during zebrafish haematopoiesis.</gtr:impact><gtr:outcomeId>56dc4bd44f8599.80651573</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>gfi1ab mutant zebrafish lines</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Using an enhancer trap approach we have generated a transgenic zebrafish line that expresses a GFP reporter gene in putative HSCs as they develop in the ventral wall of the dorsal aorta at 24 hours post-fertilisation. In combined fluorescent immunohistochemistry/fluorescent in situ hybridisation experiments we can show on the confocal microscope that in this line expression of GFP is found in indiividual cells that co-express mRNA for the transcription factors c-Myb and Runx1, two proteins that play essential roles in HSCs and progenitors. Embryos injected with a morpholino against Rbpj an essential component of the Notch signalling pathway that has been shown to be required for HSC emergence lose expression of c-myb and runx1 as well as transgene expression. The reporter is also expressed in primitive red blood cells. Its expression is maintained later in sites of active haematopoiesis. Analysis of the expression of the gene our gene trap has jumped into has revealed that the transposon effectively wiped out the expression of the trapped gene in HSC progenitors and has led to upregulation of a paralogous gene. In collaboration with a lab in Sheffield that has generated a knock-out of the paralogue we are keen to find out out what the phenotype of the double knock-out is. We have recently exchanged our lines.</gtr:description><gtr:id>52D8F0F4-425B-42DF-9B98-B901BDDE70DA</gtr:id><gtr:impact>In combination with red reporter lines (gata1-dsRed, flk1-Tomato and efnb2a-tomato) this line will allow us to isolate forming HSCs out of the zebrafish embryos for further analysis. This will include transplantation, tissue culture and biochemical analysis including transcriptome analysis. The line has been passed on to a collaborator in Sheffield.</gtr:impact><gtr:outcomeId>CECC2BA8BA3</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>transgenic zebrafish line marking emerging HSCs, qmc551</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>transgenic line that expresses a constitutively active Cre recombinase in flk1-expressing endothelial cells</gtr:description><gtr:id>B7647A0F-9F5E-4229-B762-BBE819E4C2CA</gtr:id><gtr:impact>It will allow us to recombine floxed transgenes in the zebrafish genome. This can be used to lineage trace endothelial cells or to misexpress transgenes in an endothelial-specific manner.</gtr:impact><gtr:outcomeId>EUwCoSUHTC4</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Flk1:Cre line</gtr:title><gtr:type>Model of mechanisms or symptoms - non-mammalian in vivo</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>transgenic zebrafish line that expresses a 4-hydroxytamoxifen inducible Cre recombinase in endothelial cells.</gtr:description><gtr:id>B39E4233-E8F3-45B8-B434-1EE1B3C0697D</gtr:id><gtr:impact>can be used to recombine floxed transgenes to allow the lineage tracing of endothelial cells and the misexpression of transgenes in endothelial cells during a time window defined by the treatment with 4-hydroxy tamoxifen.</gtr:impact><gtr:outcomeId>Vyq6THYwtX4</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>flk1:CreERT2</gtr:title><gtr:type>Model of mechanisms or symptoms - non-mammalian in vivo</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Three transgenic zebrafish line have been generated that allows the readout of Notch signalling in the developing zebrafish embryo. They carry fluorescent protein reporter transgenes (Venus, Cerulean, mCherry), the expression of which are driven by a rabbit beta-globin minimal promoter and 12 CSL (Su(H), Rbpj) binding sites.</gtr:description><gtr:id>2AA3CA13-2A84-499C-AA3F-5DF71AD0FBB2</gtr:id><gtr:impact>This line will allow the analysis of Notch signalling not only in the vasculature and in the blood, but in a large range of other tissues that Notch signalling plays a pivotal role in. The line will be distributed to other researchers as soon as we have enough F1 fish and do no longer rely on the F0 founder fish for the generation of reporter embryos. In the last two years the Venus line has been passed on to researchers in Bath, at UCL and Sheffield.</gtr:impact><gtr:outcomeId>0B065746FD5</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>zebrafish Notch reporter lines</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>a zebrafish line (gfi1b qmc554) that carries a mutation in gfi1b</gtr:description><gtr:id>B1F1501D-552D-4616-A5D6-A7219B13AFB8</gtr:id><gtr:impact>this line will help us to unravel the roles of Gfi1 paralogs in zebrafish haematopoiesis</gtr:impact><gtr:outcomeId>56dc4c7c8e2580.92657211</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>gfi1b mutant line</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>63CDE8B1-A8C0-4C60-9C2F-15C9530942AA</gtr:id><gtr:title>Blood flow suppresses vascular Notch signalling via dll4 and is required for angiogenesis in response to hypoxic signalling.</gtr:title><gtr:parentPublicationTitle>Cardiovascular research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74ef6c05446c342f04774928d90c91f6"><gtr:id>74ef6c05446c342f04774928d90c91f6</gtr:id><gtr:otherNames>Watson O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0008-6363</gtr:issn><gtr:outcomeId>pm_12465_25_23812297</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C976D20F-2FFE-4858-802B-51515696C4C8</gtr:id><gtr:title>5-hydroxymethyl-cytosine enrichment of non-committed cells is not a universal feature of vertebrate development.</gtr:title><gtr:parentPublicationTitle>Epigenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/554888849f9058347fc5093fe6a0ca4f"><gtr:id>554888849f9058347fc5093fe6a0ca4f</gtr:id><gtr:otherNames>Almeida RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1559-2294</gtr:issn><gtr:outcomeId>pm_12465_25_22419071</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63142E08-BCDD-4072-A003-B2EE084630FE</gtr:id><gtr:title>Wallerian Degeneration Is Executed by an NMN-SARM1-Dependent Late Ca(2+) Influx but Only Modestly Influenced by Mitochondria.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5729828fb87a41a97f714502736bcd74"><gtr:id>5729828fb87a41a97f714502736bcd74</gtr:id><gtr:otherNames>Loreto A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56dc491e658b79.09070547</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6BFA048-FEBF-4A7A-9250-06791331E3E5</gtr:id><gtr:title>The miR-30 microRNA family targets smoothened to regulate hedgehog signalling in zebrafish early muscle development.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/07a12283f0dab3df9ebfe8dbc12c7130"><gtr:id>07a12283f0dab3df9ebfe8dbc12c7130</gtr:id><gtr:otherNames>Ketley A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_12465_25_23755189</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>631E4E7F-9642-4F96-83F6-81B3084E0D88</gtr:id><gtr:title>NMN Deamidase Delays Wallerian Degeneration and Rescues Axonal Defects Caused by NMNAT2 Deficiency In&amp;nbsp;Vivo.</gtr:title><gtr:parentPublicationTitle>Current biology : CB</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4567fd8ee15a273550144bd1ab1c52af"><gtr:id>4567fd8ee15a273550144bd1ab1c52af</gtr:id><gtr:otherNames>Di Stefano M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0960-9822</gtr:issn><gtr:outcomeId>58c2efba3aad16.62751670</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E97EB986-FC63-4A51-8AFB-79C2338BBFBB</gtr:id><gtr:title>Loss of function of parathyroid hormone receptor 1 induces Notch-dependent aortic defects during zebrafish vascular development.</gtr:title><gtr:parentPublicationTitle>Arteriosclerosis, thrombosis, and vascular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ae0e7ebdbeb48e17295c01f1e1c2f20"><gtr:id>7ae0e7ebdbeb48e17295c01f1e1c2f20</gtr:id><gtr:otherNames>Gray C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1079-5642</gtr:issn><gtr:outcomeId>pm_12465_25_23559631</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>051C6CF5-06E8-4F83-9145-CC4A14739B7F</gtr:id><gtr:title>A gene trap transposon eliminates haematopoietic expression of zebrafish Gfi1aa, but does not interfere with haematopoiesis.</gtr:title><gtr:parentPublicationTitle>Developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/389fbc17670ddcf503e58462dcef63e6"><gtr:id>389fbc17670ddcf503e58462dcef63e6</gtr:id><gtr:otherNames>Thambyrajah R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0012-1606</gtr:issn><gtr:outcomeId>585d6d98448431.47434377</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/J000841/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>